MICROBIOLOGÍA
Saila
Hospital Universitario Virgen de la Victoria
Málaga, EspañaHospital Universitario Virgen de la Victoria -ko ikertzaileekin lankidetzan egindako argitalpenak (27)
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
2021
-
A pandemic within other pandemics. When a multiple infection of a host occurs: Sars-cov-2, hiv and mycobacterium tuberculosis
Viruses, Vol. 13, Núm. 5
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
2020
-
Factors associated with the number of drugs in darunavir/cobicistat regimens
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214
-
High Prevalence of Sequences Included in Transmission Clusters within Newly Diagnosed HIV-1 Patients in Southern Spain (2004-2015)
Microbial Drug Resistance, Vol. 26, Núm. 9, pp. 1090-1097
2019
-
Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy
Annals of Hematology, Vol. 98, Núm. 8, pp. 1953-1959
-
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
PLoS ONE, Vol. 14, Núm. 8
-
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 6, pp. 1693-1700
2018
-
Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain
PLoS ONE, Vol. 13, Núm. 1
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
-
Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
Journal of the International Association of Providers of AIDS Care, Vol. 17
2017
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
-
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme
PLoS ONE, Vol. 12, Núm. 3
-
Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing
Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY
2016
-
Aspectos farmacológicos de darunavir/cobicistat
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, pp. 30-33
-
Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 357-361
-
Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 35, Núm. 5, pp. 815-819
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
2015
-
Sífilis e infección por el virus de la inmunodeficiencia humana: Una endemia en hombres que tienen sexo con hombres
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 1, pp. 32-36